A rationalization of treatment of central retinal artery occlusion.
D000086:Acetazolamide / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D001161:Arteriosclerosis / Q000150:complications; D001167:Arteritis / Q000150:complications; D001799:Blood Sedimentation; D004617:Embolism / Q000150:complications; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008405:Massage; D011677:Punctures; D012039:Regional Blood Flow; D012160:Retina / Q000098:blood supply / Q000378:metabolism; D012161:Retinal Artery / Q000187:drug effects; D012166:Retinal Hemorrhage / Q000150:complications; D013035:Spasm / Q000150:complications; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents; D000086:Acetazolamide